Prevention and control of HIV/AIDS in China:lessons from the past three decades

作     者：Jun-Jie Xu Meng-Jie Han Yong-Jun Jiang Hai-Bo Ding Xi Li Xiao-Xu Han Fan Lv Qing-Feng Chen Zi-Ning Zhang Hua-Lu Cui Wen-Qing Geng Jing Zhang Qi Wang Jing Kang Xiao-Lin Li Hong Sun Ya-Jing Fu Ming-Hui An Qing-Hai Hu Zhen-Xing Chu Ying-Jie Liu Hong Shang 

作者机构：NHC Key Laboratory of AIDS Immunology(China Medical University)National Clinical Research Center for Laboratory MedicineThe First Affiliated Hospital of China Medical UniversityShenyangLiaoning 110001China Key Laboratory of AIDS Immunology of Liaoning ProvinceThe First Affiliated Hospital of China Medical UniversityShenyangLiaoning 110001China Key Laboratory of AIDS ImmunologyChinese Academy of Medical SciencesShenyangLiaoning 110001China Collaborative Innovation Center for Diagnosis and Treatment of Infectious DiseasesHangzhouZhejiang 310003China National Center for AIDS/STD Control and PreventionChinese Center for Disease Control and PreventionBeijing 102206China National Clinical Research Center of Cardiovascular DiseasesState Key Laboratory of Cardiovascular DiseasesFuwai HospitalNational Center for Cardiovascular DiseasesChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing 100037China. 

出 版 物：《Chinese Medical Journal》 (中华医学杂志（英文版）)

年 卷 期：2021年第134卷第23期

页      面：2799-2809页

核心收录：

学科分类：1004[医学-公共卫生与预防医学(可授医学、理学学位)] 100401[医学-流行病与卫生统计学] 10[医学] 

基　　金：the Mega-Projects of national science research(13rd Five-Year Plan[No.2017ZX10201101]) the Innovation Team Develop-ment Program of the Ministry of Education 2016(No.IRT_16R70) 

主　　题：Human immunodeficiency virus Acquired immunodeficiency syndrome Antiretroviral therapy Transmission route HIV-1 subtype 

摘      要：In the past 37 years,human immunodeficiency virus/acquired immunodeficiency syndrome(HIV/AIDS)has undergone various major transmission routes in China,with the world most complex co-circulating HIV-1 subtypes,even the prevalence is still *** response to the first epidemic outbreak of HIV in injecting drug users and the second one by illegal commercial blood collection,China issued the Anti-Drug Law and launched the Blood Donation Act and nationwide nucleic acid testing,which has avoided 98,232 to 211,200 estimated infections and almost ended the blood product-related *** has been providing free antiretroviral therapy(ART)since 2003,which covered80%of the identified patients and achieved a viral suppression rate of 91%.To bend the curve of increasing the disease burden of HIV and finally end the epidemic,China should consider constraining HIV spread through sexual transmission,narrowing the gaps in identifying HIV cases,and the long-term effectiveness and safety of ART in the future.